NCT04313712View on ClinicalTrials.gov

Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Blast or Combat ExposureHead Injury Trauma
Interventions
DRUG

ibogaine with magnesium treatment

Participants will receive magnesium sulfate intravenously and ibogaine orally.

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER